$SHAK

Shake Shack Inc.

0
1
0

No SEC Form 4 filings for $SHAK in the last 30 days.

See all $SHAK insider activity →
Med

SHAK Maintained by UBS -- Price Target Raised to $73.00

UBS raised Shake Shack's (SHAK) price target to $73 from $68, maintaining a Neutral rating. GuruFocus values SHAK at $120.56, suggesting a 43.7% undervaluation. The company has a GF Score of 80/100, with strong growth but weaker financial strength. Six gurus hold SHAK, with five recently adding positions.

Guggenheim cuts Shake Shack stock price target on lower EBITDA outlook

Guggenheim reduced its price target for Shake Shack (SHAK) to $90 from $100, citing lower EBITDA projections. The stock is currently trading at $68.77, down 32% in six months. Guggenheim maintains a Buy rating, expecting stable margins due to beef price relief. Other analysts have mixed views, with some raising targets and others initiating coverage.

SHAK sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 1 news story mentioning SHAK (Shake Shack Inc.). Coverage has been balanced: 0 bullish, 1 neutral, and 0 bearish.

Recent SHAK coverage spans financial news, sector analysis and earnings.

What's driving SHAK

AlphAI scores every news story that mentions SHAK with an AI model for sentiment and relevance, and aggregates insider trades from Shake Shack Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $SHAK

Score

America’s restaurants face a dilemma: How to sell food in the GLP-1 era

Restaurants are adapting menus for customers using GLP-1 weight-loss medications, which reduce appetite. McDonald's (MCD) and Burger King (QSR) are testing smaller, protein-rich options, while Shake Shack (SHAK) introduced a 'Good Fit' menu. Rising food and labor costs, along with reduced spending by diners, are challenging profitability, with one-third of restaurants reporting losses in 2026. Restaurateurs are exploring creative solutions to balance demand and costs.

Below-Expected Earnings Pressured Shake Shack (SHAK) in Q2

Shake Shack (SHAK) underperformed in Q2 2026, with shares down 27.25% in one month and 45.34% year-over-year. The company missed earnings expectations, citing higher gas prices, geopolitical factors, and rising beef costs. As of September 18, 2026, SHAK closed at $54.88 with a market cap of $2.35 billion. Carillon Eagle Small Cap Growth Fund noted the stock's lag in its investor letter.

Starbucks initiated, Expedia downgraded: Wall Street's top analyst calls

Analysts made several rating changes: Wolfe upgraded Paychex (PAYX) citing stable employment trends. UBS upgraded Union Pacific (UNP) to Buy with a $339 price target, expecting strong 2027 volume growth. Needham upgraded Rocket Pharmaceuticals (RCKT) to Buy with a $9 target after FDA reaffirmed study design. JPMorgan upgraded Credicorp (BAP) to Overweight with a $482 target, seeing strong EPS growth. Morgan Stanley downgraded Expedia (EXPE) to Underweight with a $235 target, citing weaker assets

SpaceX initiated, Intel upgraded: Wall Street's top analyst calls

Analysts upgraded Intel (INTC) to Outperform with a $120 target, citing business progress and CPU shortages. Airbnb (ABNB) was upgraded to Outperform with a $200 target, highlighting growth and AI opportunities. Synopsys (SNPS) was upgraded to Overweight with a $500 target, citing Ansys integration. Lockheed Martin (LMT) was upgraded to Buy with a $674 target, expecting 9% annual revenue growth. Costco (COST) was upgraded to Buy with a $1,030 target, noting strong retail performance. Best Buy (B

$INTCMed

Here Are Tuesday’s Top Wall Street Analyst Research Calls: Amgen, Baidu, Best Buy, Circle Internet, Corning, Intel, Lockheed Martin SpaceX, TeraWulf and More

Intel (INTC) upgraded to Outperform with $120 target at Northland. Lockheed Martin (LMT) upgraded to Buy with $674 target at UBS. SpaceX (SPCX) initiated Buy with $220 target at Pivotal. August payrolls exceeded expectations, increasing rate hike odds. Bitcoin volatile post-jobs report, trading at $78,210.

Related tickers